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Introduction
In the cells facing with an extracellular stimulus, the
first genes which responding to the stimulus are imme-
diate early genes (IEGs) and the proteins which are
members of transcription factor activator protein-1
(AP-1) are the nuclear products of this group of genes.
Function of transcription factors is to regulate the gene
transcription. Many cellular function take place
depending on transcription factors [1-3]. AP-1 tran-
scription complex functions in several cellular
processes such as growth, proliferation, differentia-
tion, apoptosis and oncogenic transformation [4]. AP-
1 is an inducible transcription factor and consists of
multiple protein complexes like many transcription
factors [3,5]. 
AP-1 transcription factor complex mainly consists
of Fos protein family (c-Fos, FosB and its smaller
splice variant FosB2, Fra-1 and Fra-2), Jun protein
family (c-Jun, JunB and JunD), activating transcrip-
tion factor (ATF) subfamily (ATFa, ATF-1 ATF-2, and
ATF-3) and  Jun dimerization protein (JDP) subfamily
(JDP-1 and JDP-2) members. All AP-1 proteins are
characterized by a basic leucine-zipper region [6-9].
AP-1 proteins are unite through these specific points
located on them and compose dimmers [3,6]. Also,
they bind to the promoter regions on DNA containing
TPA (12-O tetradecanoylphorbol 13-acetate) response
element (TRE; TGAC/GTCA) by these regions to reg-
ulate the expression of last gene responses and make
changes in the cell [6,8]. 
ATF-2 and Fos proteins are commonly seen in
pathological processes. Recent studies have shown
that over-expression of ATF-2 increases the prolifera-
tion in human and mouse cancer cells [10,11]. Again,
in studies performed, it is suggested that over-expres-
sion of Fra-2 is associated with the phenotype of
aggressive tumour at some cancers and may be related
to the progress of some cancer types and Fos-related
antigen-2 (Fra-2) is showed to be an important AP-1
transcription factor in differentiating cells [4,8,12]. 
During tooth eruption, c-Fos is expressed from den-
tal follicle (DF) cells and this expression has an impor-
tant role in tooth eruption [13-15]. 
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Abstract: It is asserted that epithelial rests in dental follicle (DF) existing around the impacted teeth in adults are effective
in cyst formation. In this study, it is intended for determining and comparing the immunoreactivity (IR) ratio of ATF-2 and
Fra-2 proteins, the members of Activator Protein-1 (AP-1) family which regulates important cellular activities such as
growth, proliferation and differentiation, in DF epithelial cells (EC) and connective tissue cells (CC).  In this study, ATF-2
and Fra-2 immunoreactivity (ATF-2-IR and Fra-2-IR) in EC and CC in DF tissues obtained from 30 patients were analyzed
by using immunohistochemical method. Ratios of ATF-2-IR positive cells were found 17.36±9.55% in EC, 27.27±14.86%
in CC and ratios of Fra-2-IR positive cells were found 20.04±11.47% in EC, 16.71±9.05% in CC. In the statistically com-
parison performed; significant differences were found between EC and CC in terms of both ATF-2-IR (p<0.001) and Fra-2-
IR (p<0.05). In EC, no significant difference was found between ATF-2-IR and Fra-2-IR (p>0.05), whereas significant dif-
ference was found between ATF-2-IR and Fra-2-IR in CC (p<0.001). According to these data, it can be suggested that Fra-2
protein may be more effective than ATF-2 protein in cyst formation originated from EC of DF. Besides, finding that ATF-
2-IR and Fra-2-IR are different in CC although similar in EC shows that AP-1 members can be expressed at different ratios
in same tissues. 
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DF is an ectomesenchymal tissue which covers the
surrounding of tooth germ and includes several cell
types. In human, DF involves cementoblast precursors,
periodontal ligament cells and osteoblasts [16-18] and
forms cementum, periodontal ligament and parts of
alveolar bone that are close to tooth [19,20]. 
Since DF present around the unerupted impacted
teeth in adults can undergo some pathological changes
especially dentigerous cyst (follicular cyst), it is
argued that it is required to be removed surgically dur-
ing extraction of impacted teeth [21].  
Follicular cysts are claimed to be originating from
epithelial rests in DF cells [22]. It is stated that apop-
tosis and cell proliferation are effective in formation of
dentigerous cysts surrounding the crown of impacted
teeth [20]. 
However, there is not sufficient number of research
with respect to the expressions of AP-1 member pro-
teins and their roles in the pathological development in
cystic structures developing from the epithelial cell
rests contained by DF around the teeth which have
completed their development but not erupted.
In this study, it is intended for determining and
comparing immunoreactivity (IR) of ATF-2 and Fra-2
proteins, the members of Activator Protein-1 (AP-1)
family which plays important roles in many cellular
activities such as proliferation and apoptosis that is
also required for cyst development in tissues forming
DF present around the impacted teeth.
Materials and methods
Tissue samples. In this study, DFs which are present around
unerupted impacted teeth and which have been extracted surgical-
ly together with these teeth were used, however DFs which have
been found to turn into cystic structure clinically and radiological-
ly were not used. DFs were obtained from 30 patients (17 males,
13 females) whose ages were between 18 and 39 (average of age
25.86±6.95). 
The freshly obtained DFs were fixed in 10% neutral buffered
formalin for 12-18 hours. After fixation process, the tissues; for the
purpose of removing fixation solution, were washed in PBS (Phos-
phate Buffered Saline) solution (pH 7.3, Zymed, CA) which was
changed 5-6 times.  
Washed tissues were dehydrated by taking into alcohol series
at the rates increasing respectively. After being become transparent
through xylene, DFs were embedded in paraffin blocks and sec-
tions with the thickness of 5-6 microns were taken. As 6 sections
for each protein to be examined from every tissue block, 12 sec-
tions were taken (excluding sections to be used for negative con-
trol, total 360 sections). After sections were mounted on glass
slides, for the purpose of removing from paraffin, they were taken
into xylene solution twice as 30 minutes in each one, they were
rehydrated by taking into alcohol series at the decreasing rates for
preparing to immunohistochemical staining. 
Immunohistochemistry. After the tissue sections were rehydrated,
they were heated in sodium citrate buffer (pH 6.0) (ZYMED, CA)
at 95°C for 15 minutes for antigen retrieval. Then, they were left
for cooling for 25 minutes.
For blocking endogenous peroxidase activity, sections were
incubated for 10 minutes at room temperature in 3% hydrogen per-
oxide solution. After sections were washed with PBS for 10 min-
utes, for the purpose of preventing non-specific background stain-
ing, they were incubated for 10 minutes at room temperature in
serum blocking solution (Histostain-Plus Bulk Kit, ZYMED, CA). 
Then, tissue sections were incubated for 6 hours with ATF-2
(ATF-2 (C-19): sc-187, Santa Cruz Biotechnology, Inc., CA) and
Fra-2 (Fra-2 (L-15): sc-171, Santa Cruz Biotechnology, Inc., CA)
antibodies which are primary antibodies (rabbit polyclonal anti-
bodies) composed against the proteins to be determined. 
Primary antibodies were diluted (ATF-2; 1:100 and Fra-2;
1:80) by antibody diluent solution (ZYMED, CA) prior to use.
Preparations reserved for negative control were incubated with
non-immune rabbit serum instead of primary antibodies. After pri-
mary antibodies, the sections were  incubated for 10 minutes with
biotinylated secondary antibody (Histostain-Plus Bulk Kit,
ZYMED, CA). 
Immunoreactivity was determined through the incubation of
tissues with horseradish-peroxidase (HRP)-streptavidin complex
(Histostain-Plus Bulk Kit, ZYMED, CA) for 10 minutes and
aminoethyl carbazole substrate (AEC) chromogen (AEC (red)
Substrate Kit, ZYMED, CA) for 15 minutes as a marker. Counter-
stain was applied to the sections for 0,5-2 minutes with Mayer's
hematoxylin. 
After sections were washed in distilled water which was
changed 3 times, they were closed with mounting media
(UltraMount Plus, Lab Vision Corporation, CA) and examined by
light microscope and were photographed. 
Ethical issues. The study protocol was approved by the Ethics
Committee of Istanbul University Istanbul Faculty of Medicine
(2006/2059). 
Statistical analysis. For statistically comparing ATF-2 and Fra-2
immunoreactivity (ATF-2-IR and Fra-2-IR) in epithelial cells (EC)
and connective tissue cells (CC) of DFs, paired samples t-test was
used. Statistically significance degree was accepted as p<0.05. 
Results 
In EC and CC forming DF, both ATF-2-IR and Fra-2-
IR positive cells were detected in different propor-
tions. The percentage of EC and CC which were ATF-
2-IR and Fra-2-IR positive within the cell group they
belong to were calculated. 
ATF-2-IR positive cell rates were calculated as
17.36±9.55% in EC, and as 27.27±14.86% in CC. Fra-
2-IR positive cell rates were calculated as
198 I. Bolat and N. Keklikoglu
©Polish Histochemical et Cytochemical Society
Folia Histochem Cytobiol. 2010:48(2): 198 (197-201) 
10.2478/v10042-008-0110-8
Table 1. Percentage of cells with positive ATF-2 and Fra-2 –
immunostaining in epithelial cells (EC) and connective tissue cells
(CC) in human dental follicle. 
* paired-samples t-test.
20.04±11.47% in EC and 16.71±9.05% in CC (Table
1). In ATF-2-IR positive EC and CC, both nuclear and
cytoplasmic staining were observed (Fig. 1 and 2).
Nuclear staining was observed predominant in Fra-2-
IR positive EC, whereas both cytoplasmic and nuclear
staining were observed in CC (Fig. 3 and 4).
While ATF-2-IR positive cell rate was found high-
er in CC than EC, Fra-2-IR positive cell rate was found
higher in EC than CC (Table 1). In the statistical com-
parison (paired samples t-test), a highly significant dif-
ference was found between EC and CC in terms of
ATF-2-IR (p<0.001), whereas significant difference
was found in terms of Fra-2-IR (p<0.05). 
In the statistical comparison of ATF-2-IR and Fra-
2-IR in each one of  EC and CC, no significant differ-
ence was found between ATF-2-IR and Fra-2-IR in EC
(p>0.05), whereas a highly significant difference was
found in the comparison of ATF-2-IR and Fra-2-IR in
CC (p<0.001) (Table 1). 
Discussion
It is suggested that DF which is a dense ectomes-
enchymal tissue surrounding the crown part of
impacted teeth may be the cause of dentrigerous (fol-
licular) cysts because of containing epithelial rests
(Malassez epithelial rests) [23-25]. During the surgi-
cally extraction of impacted teeth, DF is recommend-
ed to be extracted under the opinion that it may cause
cyst formation by undergoing pathological transfor-
mations [21].
In literature, there is not any sufficient information
yet about the expression rate of AP-1 transcription fac-
tors under physiological  conditions. Furthermore, no
enough evidence regarding that there is a correlation
between number of the cells  which the proteins ana-
lyzed in this study are expressed in and  general activ-
ity of the proteins in the tissue. In this study, given the
known general characteristics of AP-1 transcription
factors (like managing proliferation, differentiation
and apoptosis in cells), the effects of AP-1 on cyst 
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Fig. 1. ATF-2 immunoreactivity in epithelial cells of human dental follicle (arrows, original magnification ×400). Fig. 2. ATF-2
immunoreactivity in connective tissue cells of human dental follicle (arrows, original magnification ×400). Fig. 3. Fra-2 immunoreactiv-
ity in epithelial cells of human dental follicle (arrows, original magnification ×400). Fig. 4. Fra-2 immunoreactivity in connective tissue
cells of human dental follicle (arrows, original magnification ×400).  
formation which is the most frequent pathological
change of DF have been evaluated.
ATF-2 and Fra-2 which are the members of AP-1
transcription factors play important roles in growth,
differentiation, apoptosis and cancer processes in cell
[26-29]. In view of their cellular functions, it can be
predicted that these proteins may be effective in cyst
formation originating from epithelial cells of DF. 
Since DF is disappeared when completed its func-
tion during healthy eruption of teeth, there is not any
tissue we can compare as a control group for DF tis-
sues in adults. Additionally, EC do not compose a reg-
ular epithelial tissue in DF. This situation raises diffi-
culties in manual counts. Since EC is held responsible
for cyst formation, in this study, CC was not separated
according to its types, but all cells composing the tis-
sue were counted. 
According to the results of our study, when ATF-2-
IR is compared between EC and CC of DF, it is high-
er in CC than EC, and therefore it is determined that
ATF-2 protein expression may not be effective on
epithelial-origin cyst formation in DF.  When Fra-2-IR
is compared between EC and CC of DF, Fra-2 protein
expression is higher in EC than CC, and therefore
when the effect of Fra-2 expression on cellular
processes is considered, it is determined that it may be
more effective in cyst formation processes than ATF-2. 
However, when ATF-2-IR and Fra-2-IR in each tis-
sue is compared, despite a statistically significant dif-
ference not being found between the expressions of
two proteins in EC weakens the hypothesis that Fra-2
may be effective on cyst formation, it should not be
ignored that these proteins may show different effects
at different rates. When considered that each one of
AP-1 member proteins does not play an equal role in
all of the cellular processes and each one is not
expressed at similar rates for their effects on these
processes [30], the possibility that Fra-2 protein which
is expressed more in EC than CC may have a patho-
logical effect in epithelial cells and may be responsible
for cyst formation increases. 
In Fra-2 -IR-positive cells in EC of DF, a more
intensive nuclear staining was observed than ATF-2-
IR-positive cells. This intensive nuclear staining sug-
gests that Fra-2 protein may has different effects on
cellular and pathological processes in EC in compari-
son with ATF-2 protein. However, information relating
to the pathobiological relevance of intracellular distri-
bution of AP-1 proteins is insufficient and confused in
the literature [31-33]. 
Observation of higher ATF-2-IR in CC of DF and
the difference with Fra-2-IR being statistically signifi-
cant (p<0.001) has showed that ATF-2 may be more
effective only in possible pathological processes orig-
inating from connective tissue of DF. Accordingly,
while researching the influencing factors in the devel-
opment of cyst or other pathologies originating from
DF, the role of possible inductive effect of ATF-2-IR in
connective tissue or inhibition of ATF-2 expression in
prevention of the pathology should be researched.  
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